Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Brenner, Philip ^a   Alexanderson, Kristina ^b   Björkenstam, Charlotte ^b   Hillert, Jan ^a   Jokinen, Jussi ^a   Mittendorfer Rutz, Ellenor ^b   Tinghög, Petter ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; LITHIUM; NEUROLEPTIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL DISORDER; DISABILITY; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROSIS; PENSION; PERSONALITY DISORDER; PRESCRIPTION; PROSPECTIVE STUDY; PSYCHOSIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; SOMATOFORM DISORDER; SUBSTANCE ABUSE; SURVIVAL; CONFIDENCE INTERVAL; DISABLED PERSON; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SWEDEN; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; DISABLED PERSONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PENSIONS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84905651090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104165     Document Type: Article

References (40)

1. Alonso A, Hernan MA (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71: 129-135.
2. Kennedy J, O'Connor P, Sadovnick AD, Perara M, Yee I, et al. (2006) Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology 26: 162-167.
3. Riise T, Kirkeleit J, Aarseth JH, Farbu E, Midgard R, et al. (2011) Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Mult Scler 17: 780-787.
4. Amato MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, et al. (2002) The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy. J Neurol 249: 152-163. (Pubitemid 34143469)
5. Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B (2006) Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosur Ps 77: 918-926. (Pubitemid 44174075)
6. WHO (2011) World Report on Disability. Geneva: WHO.
7. Tinghog P, Hillert J, Kjeldgard L, Wiberg M, Glaser A, et al. (2013) High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study. Mult Scler 19: 1923-1930.
8. Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U (2001) Depression and quality of life in multiple sclerosis. Acta neurologica Scandinavica 104: 257-261. (Pubitemid 32977143)
9. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, et al. (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. American Journal of Psychiatry 159: 1862-1868. (Pubitemid 35283251)
10. Patten SB, Williams JV, Lavorato DH, Metz LM, Bulloch AG (2012) Disability in a community population with MS with and without mental disorders. Int J Psychiatry Med 43: 51-65.
11. Pfleger CC, Flachs EM, Koch-Henriksen N (2010) Social consequences of multiple sclerosis (1): early pension and temporary unemployment-a historical prospective cohort study. Mult Scler 16: 121-126.
12. Tinghog P, Bjorkenstam C, Carstensen J, Jansson C, Glaser A, et al. (2014) Comorbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study. BMC Neurol 14: 117.
13. Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61: 1524-1527. (Pubitemid 37505573)
14. Sadovnick A, Remick R, Allen J, Swartz E, Yee I, et al. (1996) Depression and multiple sclerosis. Neurology 46: 628-632. (Pubitemid 26099623)
15. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Mood disorder and multiple sclerosis. Arch Neurol 44: 376-378. (Pubitemid 17044085)
16. Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N (2005) Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 76: 1457-1459. (Pubitemid 41360993)
17. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, et al. (2009) The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler 15: 385-392.
18. Mohr DC, Hart SL, Fonareva I, Tasch ES (2006) Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler 12: 204-208.
19. Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis 13: 67-72. (Pubitemid 46152763)
20. Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, et al. (2013) Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol 13: 16.
21. Edwards LJ, Constantinescu CS (2004) A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 10: 575-581. (Pubitemid 39207233)
22. Patten SB, Svenson LW, Metz LM (2005) Psychotic disorders in MS: population-based evidence of an association. Neurology 65: 1123-1125. (Pubitemid 41429647)
23. Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, et al. (2005) Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 231: 29-34. (Pubitemid 40432023)
24. Statistics Sweden (2003) Rikets indelningar: årsbok över regionala indelningar med koder, postadresser, telefonnummer m m. 2003. Stockholm: Statistics Sweden.
25. World Health Organization (2004) International statistical classification of diseases and related health problems: ICD-10. Vol. 1: tabular list. Geneva: World Health Organization. 1196 s. p.
26. WHO Collaborating Centre for Drug Statistics Methodology (2012) ATC classification index with DDDs, 2013. Oslo.
27. Social Insurance Agency (2012) Social insurance in figures. Stockholm: Social Insurance Agency.
28. Holm S (1979) A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6: 665-660.
29. Marrie RA, Horwitz RI (2010) Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 9: 820-828.
30. Ghaffar O, Feinstein A (2007) The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry 20: 278-285. (Pubitemid 46588302)
31. Mohr DC, Hart SL, Fonareva I, Tasch ES (2006) Treatment of depression for patients with multiple sclerosis in neurology clinics. Multiple Sclerosis 12: 204-208.
32. Lynch SG, Kroencke DC, Denney DR (2001) The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler 7: 411-416. (Pubitemid 33138353)
33. Campbell-Sills L, Cohan SL, Stein MB (2006) Relationship of resilience to personality, coping, and psychiatric symptoms in young adults. Behaviour Research and Therapy 44: 585-599. (Pubitemid 43220456)
34. Benedict RH, Priore RL, Miller C, Munschauer F, Jacobs L (2001) Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 13: 70-76. (Pubitemid 32151919)
35. National Institute for Health and Care Excellence (2011) Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults, CG113. London: National Institute for Health and Care Excellence.
36. Shakespeare DT, Boggild M, Young C (2003) Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev: CD001332.
37. Lunde HM, Bjorvatn B, Myhr KM, Bo L (2013) Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. Acta Neurol Scand Suppl: 24-30.
38. Morin CM, Benca R (2012) Chronic insomnia. Lancet 379: 1129-1141.
39. Greenblatt DJ, Roth T (2012) Zolpidem for insomnia. Expert Opin Pharmacother 13: 879-893.
40. Bombardier CH, Blake KD, Ehde DM, Gibbons LE, Moore D, et al. (2004) Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler 10: 35-40. (Pubitemid 38100524)